Long‐term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK liver transplantation database
Michael Charlton, Kris Ruppert, Steven H. Belle, Nathan Bass, Daniel Schafer, Russell H. Wiesner, Katherine Detre, Yuling Wei, James Everhart – 30 August 2004 – Hepatitis C virus (HCV)‐associated liver disease is the most common indication for liver transplantation (LT). There are, however, no long‐term (>5 year) studies of comparative outcomes for recipients with HCV infection, and no models capable of identifying recipients with HCV infection at greatest risk for adverse outcomes.